You said:
>>>sts, I am not denying any of the science regarding inflammation, just that it is not accepted in the medical community at this time or any time soon. If I were to ask my doctor to prescribe vascepa for me (I don't have high TG) for inflammation issues, he would probably look at me like I was asking him about the benefit of accupuncture for inflammation, which most docs don't recognize as medicine. Perhaps that will change over time for vascepa but I don't think it will happen in time for it to matter to us as investors in AMRN as it will be gone before that becomes accepted broadly. That is why I don't concern myself about all the stuff regarding inflammation benefits<<<
I have not emphasized any of the above, for I wish to emphasize it all as an example of old-school thinking on the part of some internists on inflammation issues. My personal physician, a former researcher at NIH, took one look at the material I sent him[probably one of JL's posts re how to convince your internist to prescribe Vascepa] + whatever else he looked up, and promptly wrote a prescription for me on a 4-month trial basis. I too do not have the very high triglycerides of >500, but they were in the 200 range. Luckily I have a regular 65-69 hdl, and ldl is only slightly elevated. Blood sugar range is elevated at times, typical of a Type I diabetic[56 year duration]. Inflammation mitigation with Vascepa is a factor which we both considered in commencing the trial.
AI
Market Data 
Markets 
